The coming Summer Olympic Games likely won’t be the positive catalyst investors might expect for Nike’s stock.
Medtronic said it agreed to acquire HeartWare International for $1.1 billion, adding more heart-treatment products to the medical-device maker.
Brexit will once again delay a return to normalcy for American banks.
Don’t count out Tesla’s offer for SolarCity just yet. No major Tesla investor has weighed in publicly, but SolarCity’s share price is at a roughly 40% discount to the offer.
PepsiCo said it would reintroduce the aspartame-sweetened version of Diet Pepsi in U.S. stores in September, its latest attempt to halt plunging diet cola sales.
Restaurant visit growth has completely stalled in the last three months, signaling that consumers, jittery over economic uncertainties, are retrenching.
Market volatility after the U.K. referendum to leave the EU threatens banks first, insurers and fund managers next.
Williams Cos. said more than two-thirds of its shareholders voted to accept an embattled deal with rival Energy Transfer Equity, a deal that may not happen because of a court ruling last week.
The revolution is finally here—raising a host of questions for regulators, providers, insurers and patients.
Britain’s vote to leave the European Union casts a shadow over the global economy. How deep a shadow depends on how the rest of the world responds, which will be driven by politics, not economics, Greg Ip writes.